Ignite Creation Date:
2025-12-24 @ 4:06 PM
Ignite Modification Date:
2026-01-02 @ 2:12 AM
Study NCT ID:
NCT03163966
Status:
COMPLETED
Last Update Posted:
2021-10-05
First Post:
2017-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis
Sponsor:
Rottapharm Biotech
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-01-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-08
First Submit QC Date:
None
Study First Post Date:
2017-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-04
Last Update Post Date:
2021-10-05
Last Update Post Date Type:
ACTUAL